$77.5 Million is the total value of Evolutionary Tree Capital Management, LLC's 31 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMBL | Exit | BUMBLE INC | $0 | – | -46,778 | -100.0% | -0.94% | – |
SYK | Exit | STRYKER CORPORATION | $0 | – | -2,650 | -100.0% | -0.97% | – |
CACI | Exit | CACI INTL INCcl a | $0 | – | -2,615 | -100.0% | -1.07% | – |
SQ | Exit | BLOCK INCcl a | $0 | – | -16,507 | -100.0% | -1.32% | – |
CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -5,650 | -100.0% | -1.43% | – |
RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -59,411 | -100.0% | -1.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HUBSPOT INC | 12 | Q3 2023 | 8.0% |
SERVICENOW INC | 12 | Q3 2023 | 8.2% |
AMAZON COM INC | 12 | Q3 2023 | 8.8% |
SAREPTA THERAPEUTICS INC | 12 | Q3 2023 | 7.9% |
SEA LTD | 12 | Q3 2023 | 6.7% |
ALPHABET INC | 12 | Q3 2023 | 6.0% |
ARROWHEAD PHARMACEUTICALS IN | 12 | Q3 2023 | 3.7% |
ARGENX SE | 12 | Q3 2023 | 4.1% |
ASCENDIS PHARMA A/S | 12 | Q3 2023 | 3.1% |
VISA INC | 12 | Q3 2023 | 5.0% |
View Evolutionary Tree Capital Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-09 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View Evolutionary Tree Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.